- Report
- September 2023
- 25 Pages
Italy
From €825EUR$920USD£735GBP
- Clinical Trials
- December 2021
- 1197 Pages
Global
From €2401EUR$2,500USD£2,067GBP
- Clinical Trials
- December 2019
- 716 Pages
Global
From €2401EUR$2,500USD£2,067GBP
- Report
- October 2018
- 58 Pages
Global
From €6147EUR$6,400USD£5,292GBP
- Report
- October 2023
- 88 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- July 2021
- 93 Pages
Global
From €3200EUR$3,569USD£2,851GBP
- Report
- October 2023
- 89 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- September 2023
- 27 Pages
Poland
From €825EUR$920USD£735GBP
- Newsletter
- May 2024
Global
From €1010EUR$1,126USD£900GBP
- Report
- September 2021
- 217 Pages
Global
From €3565EUR$3,712USD£3,069GBP
- Report
- April 2024
- 160 Pages
From €5762EUR$5,999USD£4,961GBP
- Book
- February 2023
- 256 Pages
- Book
- March 2022
- 640 Pages
- Book
- February 2022
- 1056 Pages
- Book
- March 2021
- 208 Pages
- Book
- January 2020
- 352 Pages
- Book
- January 2020
- 504 Pages
- Book
- January 2020
- 504 Pages
Dermatitis is a broad term used to describe a range of skin conditions that cause inflammation, redness, and itching. It is a common skin disorder that affects people of all ages and can be caused by a variety of factors, including allergies, irritants, and infections. Treatment for dermatitis typically involves the use of topical medications, such as corticosteroids, antibiotics, and antihistamines. In some cases, phototherapy may be used to reduce inflammation.
The dermatitis market is an important part of the dermatology industry, as it is estimated that up to 20% of the population suffers from some form of dermatitis. The market is highly competitive, with a wide range of products available to treat the condition. Companies in the dermatitis market include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Novartis. Show Less Read more